Asthma/COPD:

Indications for: TEZSPIRE

Add-on maintenance treatment of severe asthma.

Limitations of Use:

Not for relief of acute bronchospasm or status asthmaticus.

Adult Dosage:

Give by SC inj into upper arm, thigh, or abdomen (except around the navel). Rotate inj sites. 210mg once every 4 weeks.

Children Dosage:

<12yrs: not established.

TEZSPIRE Warnings/Precautions:

Not for treating acute asthma symptoms or exacerbations. Avoid abrupt discontinuation of any corticosteroids upon Tezspire initiation; reduce gradually if appropriate. Treat pre-existing helminth infections prior to initiation; if infection develops and unresponsive to antihelmintics, discontinue Tezspire until resolves. Do not inject into tender, bruised, erythematous, or hardened skin. Pregnancy (during 3rd trimester). Nursing mothers.

TEZSPIRE Classification:

Thymic stromal lymphopoietin (TSLP) blocker.

TEZSPIRE Interactions:

Avoid concomitant live attenuated vaccines.

Adverse Reactions:

Pharyngitis, arthralgia, back pain; hypersensitivity reactions (eg, rash, allergic conjunctivitis).

Generic Drug Availability:

NO

How Supplied:

Single-dose vial, single-dose prefilled syringe—1

Pricing for TEZSPIRE

210mg of 210mg/1.91ml syringe (Qty: 1)
Appx. price $3587
GoodRx